Literature DB >> 797285

Restoration of immune responsiveness in early thymectomized xenopus by implantation of histocompatible adult thymus.

S Tochinai, S Nagata, C Katagiri.   

Abstract

Larvae of the South African clawed toad, Xenopus laevis, were thymectomized at Nieuwkoop and Faber stages 45-46 (4-5 days after fertilization). The 1-1.5-year-old thymusless toads thus obtained were implanted with histocompatible thymus from 1-year-old toads, and 4 weeks later were given skin allografts or rabbit red blood cells (RRBC) to determine their immune response. In contrast with the perfectly tolerant thymusless controls, the thymus-implanted toads rejected skin allografts after longer survival times (25-66 days) than the nonthymectomized controls (18 - 19 days). Accelerated rejection (15 - 27 days) of the second-set skin allografts was evident in the thymus-implanted individuals. Similarly, the capacity of antibody production against RRBC was restored to the thymus-implanted toads to roughly the normal extent. Implantation of thymus also restored the histological features of the spleen in thymectomized toads. The experiments clearly demonstrate that in Xenopus the thymus plays an essential role for immunity at the early stages of its histogenesis. The restorative capacity of the adult thymus is also stressed.

Entities:  

Mesh:

Year:  1976        PMID: 797285     DOI: 10.1002/eji.1830061010

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  Quantitative study of regression and regeneration of the thymic cell population after X-irradiation in the newtPleurodeles waltlii Michah.

Authors:  Yehia Moustafa; Pierre Chibon
Journal:  Wilehm Roux Arch Dev Biol       Date:  1984-02

2.  "Double-duty" conventional dendritic cells in the amphibian Xenopus as the prototype for antigen presentation to B cells.

Authors:  Harold R Neely; Jacqueline Guo; Emily M Flowers; Michael F Criscitiello; Martin F Flajnik
Journal:  Eur J Immunol       Date:  2018-02-14       Impact factor: 5.532

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.